Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)

Summary

The purpose of this study is to assess to what extent sequential treatment with odanacatib results in incremental gains in bone mineral density (BMD) over time in female participants who have received at least 3 years of bisphosphonate therapy. It was hypothesized that odanacatib treatment would increase femoral neck BMD relative to placebo after 24 months.

Timeline

Start

2013-03-14

Primary completion

2014-11-11

Completion

2014-11-11

Outcome

Outcome not reported

Stopped (Enrollment): “Study halted prematurely due to low enrollment.”

Drugs

Indications